CN104288296A - 一种治疗胆结石的中药组合物 - Google Patents
一种治疗胆结石的中药组合物 Download PDFInfo
- Publication number
- CN104288296A CN104288296A CN201410625113.0A CN201410625113A CN104288296A CN 104288296 A CN104288296 A CN 104288296A CN 201410625113 A CN201410625113 A CN 201410625113A CN 104288296 A CN104288296 A CN 104288296A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- radix
- herba
- cholelithiasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 201000001883 cholelithiasis Diseases 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 239000000454 talc Substances 0.000 claims abstract description 16
- 235000012222 talc Nutrition 0.000 claims abstract description 16
- 229910052623 talc Inorganic materials 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 4
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- -1 Herba Glechomae Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 208000009911 Urinary Calculi Diseases 0.000 abstract description 2
- 239000001138 artemisia absinthium Substances 0.000 abstract description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 2
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 206010007027 Calculus urinary Diseases 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000011755 Nepeta hederacea Nutrition 0.000 abstract 1
- 244000215554 Nepeta hederacea Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 13
- 230000036407 pain Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 210000000232 gallbladder Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 7
- 239000004575 stone Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241001249148 Artemisia scoparia Species 0.000 description 1
- 235000003069 Artemisia scoparia Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000717671 Glechoma longituba Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000961970 Plantago depressa Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000007457 cholecystostomy Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000009705 sanhuang Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 150000004760 silicates Chemical group 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药技术领域,公开了一种治疗胆结石的中药组合物,其特征在于,由连钱草、滑石、黄芪、茵陈、青皮、车前子、木香和甘草等8味药材制备而成。以上8味药材伍用,可利水、通淋、排石。
Description
技术领域
本发明属于中药技术领域,涉及中药组合物,具体涉及一种用于治疗胆结石的中药组合物和制法及应用。
背景技术
胆结石属于中医胆胀、胁痛、黄疸等范畴。中医学认为,本病以情志不调、饮食不节、感受外邪、感染虫积等为主要致病因素。病位主要在肝、胆,涉及脾、胃。病机要点为肝胆失疏,胆失通降,胆汁郁结,形成结石,结石阻塞,胆腑不通。
西医通过经皮经肝胆囊穿刺置管的方法,接触溶石,给药治疗,但病人疼痛厉害,需要用麻醉来缓解病人疼痛症状。手术开刀取石,会让病人元气大伤,而且术后可能会有并发症。因此采用手术治疗胆结石,给病人带来较多的麻烦和痛苦,不易被接受,特别是手术后结石的复发率较高,在临床上不是首选的治疗方法,另一种是体外碎石,尽管此疗法有一定疗效,对于较大结石的患者,其有效率不是很高。
自古,中医就有治疗胆结石的论述,现存的古方、验方有很多种,例如排石汤、排石冲剂、清胆化石汤、疏肝利胆汤、三黄排石汤加减等等。然这些方剂虽然有效,但药味繁多、治愈率并不高,且很多药材现已不宜购得。
发明内容
本发明针对现有技术存在的缺陷,提供了一种疗效显著,治愈率高、原料易得的治疗胆结石的中药组合物。
本发明主要采用如下技术方案来实现本发明的目的:
一种治疗胆结石的中药组合物,由连钱草、滑石、黄芪、茵陈、青皮、车前子、木香和甘草等8味药材制备而成。
优选地,本发明治疗胆结石的中药组合物,其特征在于,由以下重量份的中药材制备而成:
连钱草10000-20000、滑石5000-9000、黄芪3000-6000、茵陈3000-6000、青皮3000-6000、车前子2000-6000、木香2000-6000和甘草4000-20000。
作为优选地的技术方案之一,本发明治疗胆结石的中药组合物,其特征在于,由以下重量份的中药材制备而成:
连钱草14000、滑石6000、黄芪4000、茵陈4000、青皮5000、车前子3000、木香3000和甘草10000。
作为优选地的技术方案之二,本发明治疗胆结石的中药组合物,其特征在于,由以下重量份的中药材制备而成:
连钱草20000、滑石8800、黄芪5000、茵陈6000、青皮4000、车前子5000、木香6000和甘草16000。
各味药材的药理药性如下:
连钱草:本品为唇形科植物活血丹Glechoma longituba(Nakai)Kupr.的干燥地上部分。春至秋季采收,除去杂质,晒干。性味:辛、微苦,微寒。归经:归肝、肾、膀胱经。功能主治:清热解毒,利尿排石,散瘀消肿。用于尿路结石、肝胆结石、湿热黄疸、跌扑损伤。
滑石:本品为硅酸盐类矿物滑石族滑石,主含含水硅酸镁。采挖后,除去泥沙及杂石。性味:甘、淡,寒。归经:归膀胱、肺、胃经。功能主治:利尿通淋,清热解暑,祛湿敛疮。用于热淋,石淋,尿热涩痛,暑湿烦渴,湿热水泻;外治湿疹,湿疮,痱子。
黄芪:本品为豆科植物蒙古黄芪或膜荚黄芪的干燥根。春、秋二季采挖,除去须根及根头,晒干。性味:甘,温。归经:归肺、脾经。功能主治:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
茵陈:本品为菊科植物滨蒿或茵陈蒿的干燥地上部分。春季幼苗高6~10cm时采收或秋季花蕾长成时采割,除去杂质及老茎,晒干。春季采收的习称“绵茵陈”,秋季采割的称“茵陈蒿”。性味:苦、辛,微寒。归经:归脾、胃、肝、胆经。功能主治:清湿热,退黄疸。用于黄疸尿少,湿疮瘙痒;传染性黄疸型肝炎。
青皮:本品为芸香科植物橘及其栽培变种的干燥幼果或未成熟果实的果皮。5~6月收集自落的幼果,晒干,习称“个青皮”或“青皮子”;7~8月采收未成熟的果实,在果皮上纵剖成四瓣至基部,除尽瓤瓣,晒干,习称“四花青皮”。性味:苦、辛,温。归经:归肝、胆、胃经。功能主治:疏肝破气,消积化滞。用于胸胁胀痛,疝气,乳核,乳痈,食积腹痛。
车前子:本品为车前科植物车前或平车前的干燥成熟种子。夏、秋二季种子成熟时采收果穗,晒干,搓出种子,除去杂质。性味:甘,微寒。归经:归肝、肾、肺、小肠经。功能主治:清热利尿,渗湿通淋,明目,祛痰。用于水肿胀满,热淋涩痛,暑湿泄泻,目赤肿痛,痰热咳嗽。
木香:本品为菊科植物木香的干燥根。秋、冬二季采挖,除去泥沙及须根,切段,大的再纵剖成瓣,干燥后撞去粗皮。性味:辛、苦,温。归经:归脾、胃、大肠、三焦、胆经。功能主治:行气止痛,健脾消食。用于胸脘胀痛,泻痢后重,食积不消,不思饮食。煨木香实肠止泻。用于泄泻腹痛。
甘草:本品为豆科植物甘草、胀果甘草或光果甘草的干燥根。春、秋二季采挖,除去须根,晒干。性味:甘,平。归经:归心、肺、脾、胃经。功能主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
本发明组方重用连钱草,利水通淋、排除结石,为本方之君药,滑石、车前子辅主药利水通淋,黄芪、茵陈、青皮与连钱草伍用,可助排石之功。木香消胀止痛,甘草调和诸药。以上8味药材伍用,可利水、通淋、排石。
上述用于治疗胆结石的中药组合物,其药物剂型可以是颗粒剂、片剂、口服液、胶囊剂等常用的口服剂型。
本发明还提供了上述中药组合物的剂型的制备方法:其特征在于包含以下步骤:
1)取连钱草(相当于总量的40%),加水煎煮二次,每次1-3小时,合并煎液,静置沉淀,滤过,滤液浓缩成稠膏,备用;
2)取剩余的连钱草及其余药材,加水煎煮二次,每次1-3小时,合并煎液,滤过,滤液浓缩,放冷后,加乙醇适量,静置,取上清液,回收乙醇并浓缩成稠膏,备用。
3)将上述两种稠膏混匀,干燥,加辅料适量,制成所需制剂。
临床应用研究证实,本发明的中药组合物治疗胆结石作用显著,优于传统中药排石汤。本发明与传统中药排石汤相比具有以下有益效果:
1、治愈率高,无毒副作用。
2、药味精简,制剂服用方便。
3、制备工艺简单易行,中药材来源广泛,原料易得,价格便宜。
具体实施方式
以下通过具体实施方式的描述对本发明作进一步说明,但这并非是对本发明的限制,本领域技术人员根据本发明的基本思想,可以做出各种修改或改进,但是只要不脱离本发明的基本思想,均在本发明的范围之内。
实施例l颗粒剂的制备
处方:
连钱草14000g、滑石6000g、黄芪4000g、茵陈4000g、青皮5000g、车前子3000g、木香3000g和甘草10000g
制备方法:
1)取连钱草5600g,加10倍量水煎煮二次,每次2小时,合并煎液,静置沉淀,滤过,滤液浓缩成密度为1.15-1.25稠膏,备用。
2)取剩余的连钱草及其余药材,加10倍量水煎煮二次,每次2小时,合并煎液,滤过,滤液浓缩至密度为1.15-1.20的稠膏,放冷后,加75-80%乙醇10L,搅拌30min,静置,取上清液,回收乙醇并浓缩成密度为1.15-1.25稠膏稠膏,备用。
3)将上述两种稠膏混匀,干燥,加辅料适量,制成颗粒剂,装袋,每袋10g,含生药5g。
实施例2颗粒剂的制备
处方:
连钱草20000g、滑石8800g、黄芪5000g、茵陈6000g、青皮4000g、车前子5000g、木香6000g和甘草16000g。
制备方法:
1)取连钱草8000g,加10倍量水煎煮二次,每次2小时,合并煎液,静置沉淀,滤过,滤液浓缩成密度为1.15-1.25稠膏,备用。
2)取剩余的连钱草及其余药材,加10倍量水煎煮二次,每次2小时,合并煎液,滤过,滤液浓缩至密度为1.15-1.20的稠膏,放冷后,加75-80%乙醇10L,搅拌30min,静置,取上清液,回收乙醇并浓缩成密度为1.15-1.25稠膏稠膏,备用。
3)将上述两种稠膏混匀,干燥,加辅料适量,制成颗粒剂,装袋,每袋10g,含生药5g。
药效学实验
1、急性毒性试验
实验药物:本发明实施例1处方。
试验动物:普通级NIH小鼠10只,体重20g±2g,雌雄各半。
试验方法与结果:
1)药物配制:将10g药料粉碎,用含2%阿拉伯树胶的生理盐水配至150g/L悬液;
2)实验采用灌胃给药方式。一次性给药,容积0.2ml/10g体重,密切观察8h并作记录,继续观察7d;
3)7天中,小鼠无死亡,行为活泼,摄食量如常,毛色光亮无疏松污,无惊厥嗜唾,眼、口、鼻、耳及肛周无异常分泌物,无断尾烂趾。选择5只处死,肉眼所见:心、肝、肺、胃内及胸腺等重要脏器,未见异常改变,表明该中药无急性毒性。
2、本发明动物长期毒性试验
实验药物:本发明实施例1处方。
试验动物:SD大鼠30只,体重200g±10g,雌雄各半。
试验方法与结果:
1)药物配制:分高、中、低三个剂量组,分别为临床用药量的300、150、75倍,用含2%阿拉伯树胶的生理盐水1:1混合;
2)实验采用灌胃给药方式,连续给药24d,即3个临床周期以上,观察动物全身毒性反应及严重程度,处死后按操作规程检查各部位,并进行血液学,ALT、BUN及心、肝、脾、肺、肾、胃等主要脏器的病理学检查;
3)长期经口给药,动物未出现毒性反应。发育良好。肉眼外观及主要脏器未见异常。外周血象及血清ALT、BUN与对照组比较无病理性改变。病理报告心、肝、脾、肺、肾、胃等均未有意义的改变,认为经病理证实对动物无中毒表现。
以下结合临床资料对本发明的有益效果作进一步的说明:
1.临床资料:
所有病例选自2011年3月至2014年10月临沂市人民医院门诊及住院病人共210人,年龄为22-68岁,病程1-13年。随机分为治疗组160例,对照组50例。两组年龄、病程、性别等经统计学处理无显著性差异,具有可比性。
2.诊断标准
首先是根据病史,如常有右上腹部疼痛,并向右肩部放射、伴有发热等症状做出初步诊断,然后通过B超检查进行确诊,B超能够清晰地显示胆囊结石。肝功能检查正常。
3.治疗方法
治疗组:本发明实施例1制备的颗粒剂,每天早晚两次,开水冲服,每次1袋。15天1疗程,连服2疗程。
对照组:口服排石颗粒(成份为连钱草、车前子、关木通、石韦、瞿麦、忍冬藤、滑石、苘麻子、甘草等),广东益和堂制药有限公司生产。一日3次,开水冲服,每次1袋。15天1疗程,连服2疗程。
4.疗效评定标准
疗效评定标准参照《中药新药临床研究指导原则》制定的:
1)痊愈:临床症状体征消失,肝功能正常,肝胆B超检查正常,B超复查结石排净,1年内无复发;
2)显效:临床症状体征消失,肝功能正常,肝胆B超检查正常,大便中排出结石,B超复查结石显著减少,半年内无复发;
3)有效:临床症状体征消失,总胆红素增高,肝胆B超检查提示胆囊内结石存在,3月内无复发;
4)无效:临床症状体征及辅助检查均未见好转。
5.治疗结果
两组治疗结果如表1所示:
表1 两组治愈率对照表
组别 | 病例数 | 治愈 | 治愈率 | 显效 | 有效 | 总有效率 |
治疗组 | 160 | 125 | 78.1% | 20 | 9 | 96.3% |
对照组 | 50 | 24 | 48.0% | 11 | 6 | 82.0% |
Claims (6)
1.一种治疗胆结石的中药组合物,其特征在于,由连钱草、滑石、黄芪、茵陈、青皮、车前子、木香和甘草等8味药材制备而成。
2.根据权利要求1所述的治疗胆结石的中药组合物,其特征在于,作为优选,由以下重量份的中药材制备而成:
连钱草10000-20000、滑石5000-9000、黄芪3000-6000、茵陈3000-6000、青皮3000-6000、车前子2000-6000、木香2000-6000和甘草4000-20000。
3.根据权利要求1所述的治疗胆结石的中药组合物,其特征在于,作为优选技术方案之一,由以下重量份的中药材制备而成:
连钱草14000、滑石6000、黄芪4000、茵陈4000、青皮5000、车前子3000、木香3000和甘草10000。
4.根据权利要求1所述的治疗胆结石的中药组合物,其特征在于,作为优选技术方案之二,由以下重量份的中药材制备而成:
连钱草20000、滑石8800、黄芪5000、茵陈6000、青皮4000、车前子5000、木香6000和甘草16000。
5.根据权利要求1所述的治疗胆结石的中药组合物,其特征在于,其药物剂型可以是颗粒剂、片剂、口服液、胶囊剂等常用的口服剂型。
6.根据权利要求1所述的治疗胆结石的中药组合物:其特征在于其制备方法包含以下步骤:
1)取连钱草(相当于总量的40%),加水煎煮二次,每次1-3小时,合并煎液,静置沉淀,滤过,滤液浓缩成稠膏,备用;
2)取剩余的连钱草及其余药材,加水煎煮二次,每次1-3小时,合并煎液,滤过,滤液浓缩,放冷后,加乙醇适量,静置,取上清液,回收乙醇并浓缩成稠膏,备用;
3)将上述两种稠膏混匀,干燥,加辅料适量,制成所需制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410625113.0A CN104288296A (zh) | 2014-11-07 | 2014-11-07 | 一种治疗胆结石的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410625113.0A CN104288296A (zh) | 2014-11-07 | 2014-11-07 | 一种治疗胆结石的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104288296A true CN104288296A (zh) | 2015-01-21 |
Family
ID=52308408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410625113.0A Pending CN104288296A (zh) | 2014-11-07 | 2014-11-07 | 一种治疗胆结石的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104288296A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104840805A (zh) * | 2015-06-13 | 2015-08-19 | 王桂霞 | 一种治疗胆结石的中药配方及其制备方法 |
CN104873604A (zh) * | 2015-06-15 | 2015-09-02 | 王桂霞 | 一种治疗胆结石的中药组合物及其制备方法 |
CN105194527A (zh) * | 2015-11-16 | 2015-12-30 | 张冬 | 一种治疗肝胆结石的中药制剂 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357341A (zh) * | 2000-12-07 | 2002-07-10 | 王跃辉 | 一种治疗胆结石的药物 |
CN101579507A (zh) * | 2009-03-23 | 2009-11-18 | 路正平 | 一种治疗胆结石的药物及其制备方法 |
-
2014
- 2014-11-07 CN CN201410625113.0A patent/CN104288296A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357341A (zh) * | 2000-12-07 | 2002-07-10 | 王跃辉 | 一种治疗胆结石的药物 |
CN101579507A (zh) * | 2009-03-23 | 2009-11-18 | 路正平 | 一种治疗胆结石的药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
李占民等: "疏肝散结汤治疗胆石病的疗效观察", 《世界中西医结合杂志》 * |
辜善腾: "自拟胆石汤治疗58例胆石病", 《新中医》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104840805A (zh) * | 2015-06-13 | 2015-08-19 | 王桂霞 | 一种治疗胆结石的中药配方及其制备方法 |
CN104873604A (zh) * | 2015-06-15 | 2015-09-02 | 王桂霞 | 一种治疗胆结石的中药组合物及其制备方法 |
CN104873604B (zh) * | 2015-06-15 | 2018-10-26 | 江西致恩堂中医药科技有限公司 | 一种治疗胆结石的中药组合物及其制备方法 |
CN105194527A (zh) * | 2015-11-16 | 2015-12-30 | 张冬 | 一种治疗肝胆结石的中药制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104352991A (zh) | 一种治疗痛风的中药制剂及其制备方法 | |
CN102600426B (zh) | 一种活血化瘀的中药制剂及其制备方法 | |
CN104398841A (zh) | 一种治疗白内障、青光眼的中药制剂及其制备方法 | |
CN104288296A (zh) | 一种治疗胆结石的中药组合物 | |
CN100579562C (zh) | 一种内服治疗便秘的中药组合物 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN104474501A (zh) | 一种治疗水肿的中药制剂及其制备方法 | |
CN104524106A (zh) | 一种治疗前列腺炎、前列腺肥大的中药制剂及其制备方法 | |
CN103341092A (zh) | 一种治疗萎缩性阴道炎的散剂制备方法 | |
CN104547902A (zh) | 中药制剂用于制备治疗慢性肠炎、阑尾炎药物中的用途 | |
CN104547798A (zh) | 一种治疗慢性肠炎、阑尾炎的中药制剂及其制备方法 | |
CN105233078A (zh) | 一种用于治疗病毒性肝炎的中药组合物 | |
CN102205067B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN102145150B (zh) | 一种治疗泌尿系结石的药物 | |
CN104922499A (zh) | 一种治疗肝炎的中药 | |
CN104840891A (zh) | 一种用于酒精性心肌病的中药制剂及其制备方法 | |
CN104083548A (zh) | 一种治疗卵巢囊肿的中药组合物及其制备方法 | |
CN103908603A (zh) | 一种治疗痛风的中药组合物及其制备方法 | |
CN103656533B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN103316270B (zh) | 一种治疗产后会阴粘膜病变药物的散剂制备方法 | |
CN105943744A (zh) | 一种治疗癃闭的中药组合物 | |
CN104173952A (zh) | 一种治疗卵巢良性肿瘤的中药组合物 | |
CN104491312A (zh) | 中药制剂在制备治疗前列腺炎、前列腺肥大药物中的用途 | |
CN104940398A (zh) | 一种治疗卵巢囊肿的中药制剂及其制备方法 | |
CN104367862A (zh) | 一种治疗尿道结石的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150121 |